Brief: India's SeQuent Scientific March-Quarter Consol PAT Falls
12/05/2020 12:09
May 12 (Reuters) - SeQuent Scientific Ltd SEQU.NS :
* MARCH-QUARTER CONSOL PAT 169 MILLION RUPEES VERSUS 171
MILLION
RUPEES YEAR AGO
* MARCH-QUARTER CONSOL REVENUE 3.01 BILLION RUPEES VERSUS
2.82
BILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSE9FQ6DT
Further company coverage: SEQU.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viyash Scientific
See all newsBrief: Viyash Scientific Says Bioforlife Italia Acquisition Expected To Complete Within Two Months From Sept 8
Brief: Viyash Scientific Ltd June-Quarter Consol Net Profit 658.7 Million Rupees
Brief: Viyash Scientific's Subsidiary To Buy 100% Of Bioforlife Italia
Brief: Viyash Scientific March-Quarter Consol Net Profit 521.1 Million Rupees
Brief: Viyash Scientific Partners With Boehringer Ingelheim In India